Literature DB >> 25921161

Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.

Yong Li1, Da-Jiang Li, Jian Chen, Wei Liu, Jian-Wei Li, Peng Jiang, Xin Zhao, Fei Guo, Xiao-Wu Li, Shu-Guang Wang.   

Abstract

OBJECTIVE: To explore the application of joint detection of serum AFP, CA19-9, CA125 and CEA in identification and diagnosis of cholangiocarcinoma (CC).
MATERIALS AND METHODS: The levels of serum AFP, CA19-9, CA125 and CEA of both 30 patients with CC and 30 patients with hepatocellular carcinoma (HCC) were assessed. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic effects of single and joint detection of those 4 kinds of tumor markers for CC.
RESULTS: The levels of serum CA19-9, CA125 and CEA in CC patients were higher than that in HCC patients,whereas that of serum AFP was significantly lower s. The area under ROC curve of single detection of serum AFP, CA19-9, CA125 and CEA were 0.05, 0.86, 0.84 and 0.83, with the optimal cutoff values of 15.4 ng/ml, 125.1 U/ml, 95.7 U/ml and 25.9 ng/ml, correspondingly, and the percentage correct single diagnosis was <79%. With joint detection, the diagnostic effect of combined AFP, CA19-9, CA125 and CEA was the highest, with an area under the ROC curve of 0.94 (95%CI 0.88~0.99).
CONCLUSIONS: Single detection of serum CA19-9, CA125 and EA is not meaningful. The sensitivity, specificity, the rate of correct diagnosis and the area under ROC curve of joint detection of AFP, CA19-9, CA125 and CEA are highest, indicating that the joint detection of these 4 tumor markers is of great importance in the diagnosis of CC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921161     DOI: 10.7314/apjcp.2015.16.8.3451

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  20 in total

Review 1.  Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy.

Authors:  Domenico Viterbo; Valerie Gausman; Tamas Gonda
Journal:  World J Gastrointest Endosc       Date:  2016-02-10

2.  Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma.

Authors:  Hua Zhao; Benliang Lu
Journal:  Cancer Manag Res       Date:  2022-01-19       Impact factor: 3.989

3.  Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells.

Authors:  Tin May Aung; Atit Silsirivanit; Apinya Jusakul; Waraporn Chan-On; Tanakorn Proungvitaya; Sittiruk Roytrakul; Siriporn Proungvitaya
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

4.  Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.

Authors:  Gyem Tshering; Palden Wangyel Dorji; Wanna Chaijaroenkul; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2018-04-05       Impact factor: 2.345

Review 5.  Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.

Authors:  Xinxin Zhu; Jinghe Lang
Journal:  Oncotarget       Date:  2017-05-31

6.  Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma.

Authors:  Chaobin He; Yu Zhang; Yunda Song; Jun Wang; Kaili Xing; Xiaojun Lin; Shengping Li
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

Review 7.  lncRNAs as potential molecular biomarkers in the clinicopathology and prognosis of cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Kangfu Dai; Jing Quan; Fangli Yan; Xinghan Jin; Xiang Pan; Xiaorui Song; Shijie Zhang; Qingqi Ren; Jikui Liu; Xiaoping Liu
Journal:  Onco Targets Ther       Date:  2019-03-08       Impact factor: 4.147

8.  Pretreatment risk management of a novel nomogram model for prediction of thoracoabdominal extrahepatic metastasis in primary hepatic carcinoma.

Authors:  Jia Hu; Ting Wang; Kun-He Zhang; Yi-Ping Jiang; Song Xu; Si-Hai Chen; Yu-Ting He; Hai-Liang Yuan; Yu-Qi Wang
Journal:  J Transl Med       Date:  2019-04-08       Impact factor: 5.531

9.  Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.

Authors:  Junfei Jin; Pengpeng Zhu; Yan Liao; Jun Li; Weijia Liao; Songqing He
Journal:  Oncotarget       Date:  2015-08-07

Review 10.  Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Bin Liang; Liansheng Zhong; Qun He; Shaocheng Wang; Zhongcheng Pan; Tianjiao Wang; Yujie Zhao
Journal:  Med Sci Monit       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.